Source: Stephanie Lamm, NC BUSINESS NEWS WIRE, 3/7/17

 SynShark LLC, a bioscience company developing a method to extract specialty chemicals from tobacco, plans to raise $500,000 using debt and stock options. SynShark manager Jason M. Ornstein filed a Form D disclosing the sale on March 2.
So far, one investor has bought $213,000 of the offering, which began Jan. 27. The company expects this offering to last less than a year.

For more of this story, click here.